Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Shares withheld for taxes VP Chief Financial Officer gave up 5,930 shares (to pay taxes)
  2. 4/A Grant or award Director acquired 2,500 shares (grant or award)
  3. 4/A Grant or award Director acquired 2,500 shares (grant or award)
  4. 4/A Grant or award Director acquired 2,500 shares (grant or award)
  5. 4/A Grant or award Director acquired 6,500 shares (grant or award)
  6. 4/A Grant or award Director acquired 2,500 shares (grant or award)
  7. 4 Open-market buy Director bought 154 shares at an average $1.66 ($256)
  8. 4 Open-market buy Director bought 769 shares at an average $1.71 ($1,318)
  9. 4 Open-market buy Chairman and CEO bought 769 shares at an average $1.71 ($1,318)
  10. 4 Open-market buy Director bought 4,716 shares at an average $1.74 ($8,209)
  11. 4 Open-market buy Director bought 647 shares at an average $1.17 ($755)
  12. 4 Open-market buy Director bought 1,506 shares at an average $1.17 ($1,755)
  13. 4 Open-market buy Chairman and CEO bought 1,506 shares at an average $1.17 ($1,755)
  14. 4 Open-market buy Director bought 8,029 shares at an average $1.16 ($9,348)
  15. 4 Open-market buy Director bought 713 shares at an average $1.28 ($914)
  16. 4 Open-market buy Director bought 1,426 shares at an average $1.28 ($1,827)
  17. 4 Open-market buy Chairman and CEO bought 1,426 shares at an average $1.28 ($1,827)
  18. 4 Open-market buy Director bought 7,107 shares at an average $1.28 ($9,106)
  19. 4 Other acquisition Director acquired 446 shares (code L)
  20. 4 Other acquisition Director acquired 892 shares (code L)

Page 4 of 26 · 512 filings